Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Innovation Economy Crowd (ieCrowd), a company focused on transforming innovations into global solutions, today released details of its recently concluded top-ranked Indiegogo crowdfunding campaign and the next stage of development for the Kite Mosquito Patch ("Kite Patch") and the Kite technology platform.
ieCrowd's 45-day crowdfunding campaign, designed to enable the crowd to participate in the development of a new approach in the fight against mosquito-borne diseases, raised over 740% of its $75,000 funding goal with the support of 11,254 financial backers from around the world. The overwhelming success of the crowdfunding campaign - above and beyond the original goal - has enabled ieCrowd to expand the Kite Patch trials to include over 6.7 million hours of on-the-ground testing in Uganda. A large number of supporters and a robust response by communities on social media sites elevated Kite Patch to become the most popular fundraising campaign on Indiegogo for four weeks of its six-week duration.
Since the conclusion of the campaign, ieCrowd's team has been laying the groundwork for the next phase of development, which will include a field test in three districts in Uganda where malaria rates are often among the highest in the world. To implement the field test, ieCrowd has partnered with Pilgrim Africa, an NGO with operations throughout Uganda and the region. The field test will include more than 140,000 Kite Patches and evaluate use, durability, adaptability, form, and other product parameters. The results of this large, three-month field test will help ieCrowd's product development and science teams further refine and optimize the Kite Patch for its applicability around the world, to include a range of climates, cultures, and economic conditions. ieCrowd and Pilgrim Africa have benefited from close collaboration with the Government of Uganda. As a result, field tests remain on schedule for the later part of January.
Commenting on the conclusion of the Indiegogo campaign, Amro Albanna, ieCrowd's Chairman and CEO, said: "We are very proud of and grateful for the support we received from the crowd in this campaign. True to ieCrowd's mission, we asked the crowd to support us in developing this world-changing technology, and they responded with overwhelming generosity, excitement, and optimism. In fact, the success of the Kite Patch campaign is a perfect example of the power of ieCrowd's model. By working together, and by empowering the crowd, we can transform an innovative discovery into actual market-driven solutions."
The Kite Patch is being developed by Olfactor Laboratories, Inc. (OLI), an ieCrowd company, and will be the first consumer product using the company's patent-pending, non-toxic, spatial compounds capable of blocking mosquitoes' ability to detect carbon dioxide. OLI's work over the past three years has been supported with business infrastructure from ieCrowd, a grant from the National Institutes of Health, and collaborative agreements with federal agencies and non-profits. OLI is developing a full suite of patent-pending compounds that have been heralded as significant breakthroughs in the fight against mosquito-borne diseases, among other important uses.
OLI's Chief Scientist, Dr. Michelle Brown, commented, "the comprehensive and invaluable field testing that we are now able to undertake will help us obtain valuable data that will allow us to further optimize Kite Patch. Our next steps include finalization of the first run of Kite Patches and their deployment to the field test in Uganda. We anticipate our field work to begin in January," she said. "Our team is energized by the response from so many people. We take very seriously the fact that we're stewards of a new technology and approach that will benefit everyone around the world."
This campaign is supporting the development of the first version of the Kite Patch, which is focused on generating a 'personal cloud' capable of repelling mosquitoes for up to 48 hours. However, OLI's work extends to additional technologies being developed that form a comprehensive suite of tools in the global fight against mosquito-borne diseases.
"Repelling mosquitoes away from humans is only one step of a broader effort we're conducting. We're looking forward to announcing a number of new developments soon that will highlight the power of ieCrowd's approach and the great work being done at OLI," Brown concluded.
Pilgrim Africa's full report on the scale of the malaria problem in Uganda can be found here.
Innovation Economy Crowd (ieCrowd)
Article adapted by Medical News Today from original press release. Source:
Innovation Economy Crowd (ieCrowd)
Please use one of the following formats to cite this article in your essay, paper or report:
Crowd, Innovation Economy. "Breakthrough mosquito technology Kite Patch™ moves one step closer to market roll-out." Medical News Today. MediLexicon, Intl., 15 Sep. 2013. Web.
9 Dec. 2013. <http://www.medicalnewstoday.com/releases/266124>
Crowd, I. (2013, September 15). "Breakthrough mosquito technology Kite Patch™ moves one step closer to market roll-out." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/266124.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.